These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies. Odaka M, Yuki N, Tatsumoto M, Tateno M, Hirata K. J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485 [Abstract] [Full Text] [Related]
25. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K, Hirata K, Yuki N. Neurology; 2005 May 10; 64(9):1605-11. PubMed ID: 15883324 [Abstract] [Full Text] [Related]
27. Clinical and immunological spectrum of the Miller Fisher syndrome. Lo YL. Muscle Nerve; 2007 Nov 10; 36(5):615-27. PubMed ID: 17657801 [Abstract] [Full Text] [Related]
30. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis]. Irie S, Saito T, Kanazawa N, Ito H, Kowa H. Rinsho Shinkeigaku; 1994 May 10; 34(5):454-60. PubMed ID: 7924057 [Abstract] [Full Text] [Related]
33. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, Scarlato G. Ann Neurol; 1996 Apr 10; 39(4):539-43. PubMed ID: 8619533 [Abstract] [Full Text] [Related]
36. Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome. Morgan ML, Law N, Espino Barros Palau A, Saeed U, Yalmanchili S, Lee AG. J Neuroophthalmol; 2014 Dec 10; 34(4):377-9. PubMed ID: 25062498 [Abstract] [Full Text] [Related]